[1]
“Pre-formulation Study of Tamoxifen and Excipients in Formulation of Nanoparticle Drug Delivery System”, Pharmaceutical Communications, vol. 1, no. 1, pp. 47–53, Dec. 2022, doi: 10.55627/pharma.001.001.0197.